A new long-acting methylphenidate (Concerta).
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003913:Dextroamphetamine / Q000627:therapeutic use; D005252:Fees, Pharmaceutical; D006207:Half-Life; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D013997:Time Factors
D003692:Delayed-Action Preparations; D008774:Methylphenidate; D003913:Dextroamphetamine